Atorvastatin: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 9: Line 9:
==Overview==
==Overview==


Sandbox Atorvastatin is a HMG-COA Reductase Inhibitor drug that is FDA approved for the treatment of hyperlipidemia, prevention of cardiovascular disease. Adverse reactions include [[diarrhea]], [[arthralgia]], [[myalgia]], urinary tract infectious disease, [[nasopharyngitis]], pain, in extremity.
Atorvastatin is a HMG-COA Reductase Inhibitor drug that is FDA approved for the treatment of hyperlipidemia, prevention of cardiovascular disease. Adverse reactions include [[diarrhea]], [[arthralgia]], [[myalgia]], urinary tract infectious disease, [[nasopharyngitis]], pain, in extremity.


==Category==
==Category==


HMG-COA Reductase Inhibitor
HMG-COA Reductase Inhibitor

Latest revision as of 14:27, 24 August 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Atorvastatin calcium (Lipitor)

Amlodipine besylate/Atorvastatin calcium

Amlodipine/Atorvastatin

Ezetimibe/Atorvastatin

Overview

Atorvastatin is a HMG-COA Reductase Inhibitor drug that is FDA approved for the treatment of hyperlipidemia, prevention of cardiovascular disease. Adverse reactions include diarrhea, arthralgia, myalgia, urinary tract infectious disease, nasopharyngitis, pain, in extremity.

Category

HMG-COA Reductase Inhibitor